O	O	0	3	The	The	B-NP	DT	O	2	NMOD	O
O	O	4	11	control	control	I-NP	NN	O	0	ROOT	O
O	O	12	14	of	of	B-PP	IN	O	2	NMOD	O
O	O	15	20	lytic	lytic	B-NP	JJ	O	5	NMOD	O
O	O	21	32	replication	replication	I-NP	NN	O	3	PMOD	O
O	O	33	35	of	of	B-PP	IN	O	5	NMOD	O
O	O	36	43	Epstein	Epstein	B-NP	NNP	O	10	NMOD	O
O	O	43	44	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	44	48	Barr	Barr	I-NP	NNP	O	10	NMOD	O
O	O	49	54	virus	virus	I-NP	NN	O	6	PMOD	O
O	O	55	57	in	in	B-PP	IN	O	5	NMOD	O
O	O	58	59	B	B	B-NP	NN	B-cell_type	13	NMOD	B-cell_type
O	O	60	71	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	72	73	(	(	O	(	O	16	DEP	O
O	O	73	79	Review	Review	B-NP	NN	O	16	DEP	O
O	O	79	80	)	)	O	)	O	13	NMOD	O
O	O	80	81	.	.	O	.	O	2	P	O

O	O	83	95	Uncontrolled	Uncontrolled	B-NP	JJ	O	2	NMOD	O
O	O	96	107	replication	replication	I-NP	NN	O	13	SUB	O
O	O	108	110	of	of	B-PP	IN	O	2	NMOD	O
O	O	111	112	a	a	B-NP	DT	O	5	NMOD	O
O	O	113	118	virus	virus	I-NP	NN	O	3	PMOD	O
O	O	118	119	,	,	O	,	O	2	P	O
O	O	120	125	which	which	B-NP	WDT	O	2	NMOD	O
O	O	126	128	is	be	B-VP	VBZ	O	7	SBAR	O
O	O	129	136	harmful	harmful	B-ADJP	JJ	O	8	PRD	O
O	O	137	139	to	to	B-PP	TO	O	9	AMOD	O
O	O	140	143	the	the	B-NP	DT	O	12	NMOD	O
O	O	144	148	host	host	I-NP	NN	O	10	PMOD	O
O	O	149	151	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	152	156	also	also	B-ADVP	RB	O	13	VMOD	O
O	O	157	172	disadvantageous	disadvantageous	B-ADJP	JJ	O	13	PRD	O
O	O	173	175	to	to	B-PP	TO	O	15	AMOD	O
O	O	176	179	the	the	B-NP	DT	O	18	NMOD	O
O	O	180	185	virus	virus	I-NP	NN	O	16	PMOD	O
O	O	185	186	.	.	O	.	O	13	P	O

O	O	187	191	Most	Most	B-NP	JJS	O	2	NMOD	O
O	O	192	199	viruses	virus	I-NP	NNS	O	3	SUB	O
O	O	200	206	cannot	cannot	B-VP	MD	O	0	ROOT	O
O	O	207	214	compete	compete	I-VP	VB	O	3	VC	O
O	O	215	219	with	with	B-PP	IN	O	4	VMOD	O
O	O	220	223	the	the	B-NP	DT	O	9	NMOD	O
O	O	224	231	various	various	I-NP	JJ	O	9	NMOD	O
O	O	232	238	immune	immune	I-NP	JJ	O	9	NMOD	O
O	O	239	249	mechanisms	mechanism	I-NP	NNS	O	5	PMOD	O
O	O	250	253	and	and	O	CC	O	4	VMOD	O
O	O	254	260	become	become	B-VP	VBP	O	4	VMOD	O
O	O	261	271	eliminated	eliminate	I-VP	VBN	O	11	VC	O
O	O	272	274	in	in	B-PP	IN	O	12	VMOD	O
O	O	275	278	the	the	B-NP	DT	O	15	NMOD	O
O	O	279	285	course	course	I-NP	NN	O	13	PMOD	O
O	O	286	288	of	of	B-PP	IN	O	15	NMOD	O
O	O	289	298	infection	infection	B-NP	NN	O	16	PMOD	O
O	O	298	299	.	.	O	.	O	3	P	O

O	O	300	309	Therefore	Therefore	B-ADVP	RB	O	10	VMOD	O
O	O	309	310	,	,	O	,	O	10	P	O
O	O	311	315	only	only	B-NP	RB	O	5	NMOD	O
O	O	316	319	the	the	I-NP	DT	O	5	NMOD	O
O	O	320	324	time	time	I-NP	NN	O	10	SUB	O
O	O	325	332	between	between	B-PP	IN	O	5	NMOD	O
O	O	333	342	infection	infection	B-NP	NN	O	9	NMOD	O
O	O	343	346	and	and	I-NP	CC	O	9	NMOD	O
O	O	347	358	eradication	eradication	I-NP	NN	O	6	PMOD	O
O	O	359	366	remains	remain	B-VP	VBZ	O	0	ROOT	O
O	O	367	370	for	for	B-PP	IN	O	10	VMOD	O
O	O	371	376	these	these	B-NP	DT	O	13	NMOD	O
O	O	377	384	viruses	virus	I-NP	NNS	O	15	SUB	O
O	O	385	387	to	to	B-VP	TO	O	15	VMOD	O
O	O	388	399	proliferate	proliferate	I-VP	VB	O	11	SBAR	O
O	O	399	400	.	.	O	.	O	10	P	O

O	O	401	402	A	A	B-NP	DT	O	3	NMOD	O
O	O	403	406	few	few	I-NP	JJ	O	3	NMOD	O
O	O	407	414	viruses	virus	I-NP	NNS	O	14	SUB	O
O	O	414	415	,	,	O	,	O	3	P	O
O	O	416	420	like	like	B-PP	IN	O	14	VMOD	O
O	O	421	424	the	the	B-NP	DT	O	7	NMOD	O
O	O	425	438	Herpesviruses	Herpesvirus	I-NP	NNS	O	10	NMOD	O
O	O	439	441	or	or	O	CC	O	10	NMOD	O
O	O	442	445	the	the	B-NP	DT	O	10	NMOD	O
O	O	446	462	papillomaviruses	papillomavirus	I-NP	NNS	O	5	PMOD	O
O	O	462	463	,	,	O	,	O	14	P	O
O	O	464	471	however	however	B-ADVP	RB	O	14	VMOD	O
O	O	471	472	,	,	O	,	O	14	P	O
O	O	473	477	have	have	B-VP	VBP	O	0	ROOT	O
O	O	478	487	developed	develop	I-VP	VBN	O	14	VC	O
O	O	488	489	a	a	B-NP	DT	O	18	NMOD	O
O	O	490	503	sophisticated	sophisticated	I-NP	JJ	O	18	NMOD	O
O	O	504	512	strategy	strategy	I-NP	NN	O	15	OBJ	O
O	O	513	516	for	for	B-PP	IN	O	18	NMOD	O
O	O	517	527	persisting	persist	B-VP	VBG	O	19	PMOD	O
O	O	528	536	lifelong	lifelong	B-NP	NN	O	20	OBJ	O
O	O	536	537	,	,	O	,	O	15	P	O
O	O	538	545	usually	usually	B-ADVP	RB	O	15	VMOD	O
O	O	546	562	asymptomatically	asymptomatically	I-ADVP	RB	O	23	AMOD	O
O	O	563	565	in	in	B-PP	IN	O	23	AMOD	O
O	O	566	569	the	the	B-NP	DT	O	27	NMOD	O
O	O	570	574	host	host	I-NP	NN	O	25	PMOD	O
O	O	574	575	,	,	O	,	O	14	P	O
O	O	576	582	hiding	hide	B-VP	VBG	O	14	VMOD	O
O	O	583	587	from	from	B-PP	IN	O	29	VMOD	O
O	O	588	591	the	the	B-NP	DT	O	33	NMOD	O
O	O	592	598	immune	immune	I-NP	JJ	O	33	NMOD	O
O	O	599	605	system	system	I-NP	NN	O	30	PMOD	O
O	O	606	609	and	and	O	CC	O	29	VMOD	O
O	O	610	619	producing	produce	B-VP	VBG	O	29	VMOD	O
O	O	620	630	infectious	infectious	B-NP	JJ	O	37	NMOD	O
O	O	631	638	progeny	progeny	I-NP	NN	O	35	OBJ	O
O	O	639	641	at	at	B-PP	IN	O	37	NMOD	O
O	O	642	645	the	the	B-NP	DT	O	41	NMOD	O
O	O	646	650	same	same	I-NP	JJ	O	41	NMOD	O
O	O	651	655	time	time	I-NP	NN	O	38	PMOD	O
O	O	655	656	.	.	O	.	O	14	P	O

O	O	657	661	This	This	B-NP	DT	O	2	NMOD	O
O	O	662	670	strategy	strategy	I-NP	NN	O	3	SUB	O
O	O	671	678	depends	depend	B-VP	VBZ	O	0	ROOT	O
O	O	679	681	on	on	B-PP	IN	O	3	VMOD	O
O	O	682	683	a	a	B-NP	DT	O	6	NMOD	O
O	O	684	694	separation	separation	I-NP	NN	O	12	NMOD	O
O	O	695	697	of	of	B-PP	IN	O	6	NMOD	O
O	O	698	705	latency	latency	B-NP	NN	O	7	PMOD	O
O	O	706	709	and	and	O	CC	O	12	NMOD	O
O	O	710	713	the	the	B-NP	DT	O	12	NMOD	O
O	O	714	719	lytic	lytic	I-NP	JJ	O	12	NMOD	O
O	O	720	731	replication	replication	I-NP	NN	O	4	PMOD	O
O	O	731	732	,	,	O	,	O	3	P	O
O	O	733	739	either	either	O	CC	O	3	VMOD	O
O	O	740	742	by	by	B-PP	IN	O	14	PMOD	O
O	O	743	747	time	time	B-NP	NN	O	15	PMOD	O
O	O	748	751	due	due	B-ADJP	JJ	O	16	NMOD	O
O	O	752	754	to	to	B-PP	TO	O	17	AMOD	O
O	O	755	770	differentiation	differentiation	B-NP	NN	O	22	NMOD	O
O	O	770	771	-	-	I-NP	HYPH	O	22	NMOD	O
O	O	771	780	dependent	dependent	B-NP	JJ	O	22	NMOD	O
O	O	781	791	mechanisms	mechanism	I-NP	NNS	O	18	PMOD	O
O	O	792	794	or	or	B-PP	CC	O	14	PMOD	O
O	O	795	797	by	by	B-PP	IN	O	14	PMOD	O
O	O	798	805	spatial	spatial	B-NP	JJ	O	26	NMOD	O
O	O	806	816	separation	separation	I-NP	NN	O	24	PMOD	O
O	O	817	819	as	as	B-PP	IN	O	26	NMOD	O
O	O	820	823	the	the	B-NP	DT	O	29	NMOD	O
O	O	824	830	result	result	I-NP	NN	O	27	PMOD	O
O	O	831	833	of	of	B-PP	IN	O	29	NMOD	O
O	O	834	843	different	different	B-NP	JJ	O	34	NMOD	O
O	O	844	848	host	host	I-NP	NN	O	34	NMOD	O
O	O	849	853	cell	cell	I-NP	NN	O	34	NMOD	O
O	O	854	859	types	type	I-NP	NNS	O	30	PMOD	O
O	O	859	860	.	.	O	.	O	3	P	O

O	O	861	865	Both	Both	B-NP	DT	O	2	SUB	O
O	O	866	869	are	be	B-VP	VBP	O	0	ROOT	O
O	O	870	874	true	true	B-ADJP	JJ	O	2	PRD	O
O	O	875	878	for	for	B-PP	IN	O	3	AMOD	O
O	O	879	882	the	the	B-NP	DT	O	4	PMOD	O
O	O	883	890	Epstein	Epstein	I-NP	NNP	O	5	DEP	O
O	O	890	891	-	-	I-NP	HYPH	O	6	PMOD	O
O	O	891	895	Barr	Barr	I-NP	NNP	O	9	NMOD	O
O	O	896	901	virus	virus	I-NP	NN	O	7	OBJ	O
O	O	902	903	(	(	O	(	O	12	DEP	O
O	O	903	906	EBV	EBV	B-NP	NN	O	12	DEP	O
O	O	906	907	)	)	O	)	O	9	NMOD	O
O	O	907	908	.	.	O	.	O	2	P	O

O	O	909	910	B	B	B-NP	NN	B-cell_type	2	NMOD	B-cell_type
O	O	911	916	cells	cell	I-NP	NNS	I-cell_type	5	NMOD	I-cell_type
O	O	917	920	and	and	O	CC	O	5	NMOD	O
O	O	921	931	epithelial	epithelial	B-NP	JJ	B-cell_type	5	NMOD	B-cell_type
O	O	932	937	cells	cell	I-NP	NNS	I-cell_type	6	SUB	I-cell_type
O	O	938	942	have	have	B-VP	VBP	O	0	ROOT	O
O	O	943	944	a	a	B-NP	DT	O	9	NMOD	O
O	O	945	952	pivotal	pivotal	I-NP	JJ	O	9	NMOD	O
O	O	953	957	role	role	I-NP	NN	O	6	OBJ	O
O	O	958	960	in	in	B-PP	IN	O	6	VMOD	O
O	O	961	964	the	the	B-NP	DT	O	13	NMOD	O
O	O	965	969	life	life	I-NP	NN	O	13	NMOD	O
O	O	970	975	cycle	cycle	I-NP	NN	O	10	PMOD	O
O	O	976	978	of	of	B-PP	IN	O	13	NMOD	O
O	O	979	982	the	the	B-NP	DT	O	16	NMOD	O
O	O	983	988	virus	virus	I-NP	NN	O	14	PMOD	O
O	O	988	989	.	.	O	.	O	6	P	O

O	O	990	993	The	The	B-NP	DT	O	2	NMOD	O
O	O	994	1000	former	former	I-NP	NN	O	3	SUB	O
O	O	1001	1004	can	can	B-VP	MD	O	0	ROOT	O
O	O	1005	1011	become	become	I-VP	VB	O	3	VC	O
O	O	1012	1020	latently	latently	B-ADJP	RB	O	6	AMOD	O
O	O	1021	1029	infected	infected	I-ADJP	JJ	O	4	PRD	O
O	O	1030	1033	and	and	O	CC	O	4	VMOD	O
O	O	1034	1037	are	be	B-VP	VBP	O	4	VMOD	O
O	O	1038	1045	thought	think	I-VP	VBN	O	8	VC	O
O	O	1046	1048	to	to	I-VP	TO	O	11	VMOD	O
O	O	1049	1051	be	be	I-VP	VB	O	9	VMOD	O
O	O	1052	1055	the	the	B-NP	DT	O	14	NMOD	O
O	O	1056	1061	virus	virus	I-NP	NN	O	14	NMOD	O
O	O	1062	1071	reservoir	reservoir	I-NP	NN	O	11	PRD	O
O	O	1072	1074	in	in	B-ADVP	FW	O	14	NMOD	O
O	O	1075	1079	vivo	vivo	I-ADVP	FW	O	15	AMOD	O
O	O	1079	1080	,	,	O	,	O	3	P	O
O	O	1081	1088	whereas	whereas	O	IN	O	3	VMOD	O
O	O	1089	1092	the	the	B-NP	DT	O	20	NMOD	O
O	O	1093	1099	latter	latter	I-NP	JJ	O	21	SUB	O
O	O	1100	1104	were	be	B-VP	VBD	O	18	SBAR	O
O	O	1105	1110	shown	show	I-VP	VBN	O	21	VC	O
O	O	1111	1113	to	to	I-VP	TO	O	24	VMOD	O
O	O	1114	1116	be	be	I-VP	VB	O	22	VMOD	O
O	O	1117	1127	permissive	permissive	B-ADJP	JJ	O	24	PRD	O
O	O	1128	1131	for	for	B-PP	IN	O	25	AMOD	O
O	O	1132	1137	lytic	lytic	B-NP	JJ	O	28	NMOD	O
O	O	1138	1149	replication	replication	I-NP	NN	O	26	PMOD	O
O	O	1149	1150	.	.	O	.	O	3	P	O

O	O	1151	1158	However	However	B-ADVP	RB	O	8	VMOD	O
O	O	1158	1159	,	,	O	,	O	8	P	O
O	O	1160	1171	replication	replication	B-NP	NN	O	8	SUB	O
O	O	1172	1174	of	of	B-PP	IN	O	3	NMOD	O
O	O	1175	1178	EBV	EBV	B-NP	NN	O	4	PMOD	O
O	O	1179	1181	in	in	B-ADVP	FW	O	3	NMOD	O
O	O	1182	1186	vivo	vivo	I-ADVP	FW	O	6	AMOD	O
O	O	1187	1189	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1190	1200	controlled	control	I-VP	VBN	O	8	VC	O
O	O	1201	1210	primarily	primarily	B-ADVP	RB	O	9	VMOD	O
O	O	1211	1213	by	by	B-PP	IN	O	9	VMOD	O
O	O	1214	1218	host	host	B-NP	NN	O	14	NMOD	O
O	O	1219	1225	immune	immune	I-NP	JJ	O	14	NMOD	O
O	O	1226	1236	mechanisms	mechanism	I-NP	NNS	O	11	PMOD	O
O	O	1237	1246	selecting	select	B-VP	VBG	O	14	NMOD	O
O	O	1247	1250	for	for	B-PP	IN	O	15	VMOD	O
O	O	1251	1256	cells	cell	B-NP	NNS	O	16	PMOD	O
O	O	1257	1261	that	that	B-NP	WDT	O	17	NMOD	O
O	O	1262	1265	are	be	B-VP	VBP	O	18	SBAR	O
O	O	1266	1269	not	not	O	RB	O	19	VMOD	O
O	O	1270	1280	permissive	permissive	B-ADJP	JJ	O	19	PRD	O
O	O	1281	1284	for	for	B-PP	IN	O	21	AMOD	O
O	O	1285	1290	viral	viral	B-NP	JJ	O	24	NMOD	O
O	O	1291	1302	replication	replication	I-NP	NN	O	22	PMOD	O
O	O	1303	1305	as	as	B-PP	IN	O	24	NMOD	O
O	O	1306	1309	the	the	B-NP	DT	O	27	NMOD	O
O	O	1310	1316	result	result	I-NP	NN	O	25	PMOD	O
O	O	1317	1319	of	of	B-PP	IN	O	27	NMOD	O
O	O	1320	1321	a	a	B-NP	DT	O	31	NMOD	O
O	O	1322	1332	particular	particular	I-NP	JJ	O	31	NMOD	O
O	O	1333	1336	set	set	I-NP	NN	O	28	PMOD	O
O	O	1337	1339	of	of	B-PP	IN	O	31	NMOD	O
O	O	1340	1353	transcription	transcription	B-NP	NN	B-protein	34	NMOD	B-protein
O	O	1354	1361	factors	factor	I-NP	NNS	I-protein	32	PMOD	I-protein
O	O	1361	1362	.	.	O	.	O	8	P	O

O	O	1363	1368	These	These	B-NP	DT	O	2	NMOD	O
O	O	1369	1376	factors	factor	I-NP	NNS	O	3	SUB	O
O	O	1377	1384	control	control	B-VP	VBP	O	0	ROOT	O
O	O	1385	1388	the	the	B-NP	DT	O	5	NMOD	O
O	O	1389	1397	activity	activity	I-NP	NN	O	3	OBJ	O
O	O	1398	1400	of	of	B-PP	IN	O	5	NMOD	O
O	O	1401	1404	the	the	B-NP	DT	O	12	NMOD	O
T1	B-Entity	1405	1415	regulatory	regulatory	I-NP	JJ	B-DNA	12	NMOD	B-DNA
T1	I-Entity	1416	1425	immediate	immediate	I-NP	JJ	I-DNA	12	NMOD	I-DNA
T1	I-Entity	1425	1426	-	-	I-NP	HYPH	I-DNA	12	NMOD	I-DNA
T1	I-Entity	1426	1431	early	early	I-NP	JJ	I-DNA	12	NMOD	I-DNA
T1	I-Entity	1432	1437	genes	gene	I-NP	NNS	I-DNA	6	PMOD	I-DNA
O	O	1438	1441	and	and	O	CC	O	3	VMOD	O
O	O	1441	1442	,	,	O	,	O	3	P	O
O	O	1443	1445	in	in	B-PP	IN	O	3	VMOD	O
O	O	1446	1454	addition	addition	B-NP	NN	O	23	NMOD	O
O	O	1454	1455	,	,	O	,	O	23	P	O
O	O	1456	1461	lytic	lytic	B-NP	JJ	O	23	NMOD	O
O	O	1462	1465	and	and	I-NP	CC	O	23	NMOD	O
O	O	1466	1472	latent	latent	I-NP	JJ	O	23	NMOD	O
T2	B-Entity	1473	1478	cycle	cycle	I-NP	NN	O	23	NMOD	O
T2	I-Entity	1479	1489	regulatory	regulatory	I-NP	JJ	O	23	NMOD	O
T2	I-Entity	1490	1495	genes	gene	I-NP	NNS	O	25	SUB	O
O	O	1496	1506	negatively	negatively	B-ADVP	RB	O	25	VMOD	O
O	O	1507	1516	interfere	interfere	B-VP	VBP	O	15	SBAR	O
O	O	1517	1521	with	with	B-PP	IN	O	25	VMOD	O
O	O	1522	1526	each	each	B-NP	DT	O	28	NMOD	O
O	O	1527	1532	other	other	I-NP	JJ	O	26	PMOD	O
O	O	1533	1536	and	and	O	CC	O	25	VMOD	O
O	O	1537	1541	thus	thus	B-VP	RB	O	25	VMOD	O
O	O	1542	1546	link	link	I-VP	VBP	O	25	VMOD	O
O	O	1547	1555	cellular	cellular	B-NP	JJ	O	37	NMOD	O
O	O	1556	1559	and	and	I-NP	CC	O	37	NMOD	O
O	O	1560	1565	viral	viral	I-NP	JJ	O	37	NMOD	O
T3	B-Entity	1566	1570	gene	gene	I-NP	NN	O	37	NMOD	O
O	O	1571	1581	regulatory	regulatory	I-NP	JJ	O	37	NMOD	O
O	O	1582	1592	mechanisms	mechanism	I-NP	NNS	O	31	OBJ	O
O	O	1592	1593	.	.	O	.	O	3	P	O

O	O	1594	1605	Disturbance	Disturbance	B-NP	NN	O	12	NMOD	O
O	O	1606	1608	of	of	B-PP	IN	O	1	NMOD	O
O	O	1609	1613	both	both	O	CC	O	6	NMOD	O
O	O	1614	1617	the	the	B-NP	DT	O	6	NMOD	O
O	O	1618	1624	immune	immune	I-NP	JJ	O	6	NMOD	O
O	O	1625	1637	surveillance	surveillance	I-NP	NN	O	2	PMOD	O
O	O	1638	1640	as	as	B-CONJP	RB	O	12	NMOD	O
O	O	1641	1645	well	well	I-CONJP	RB	O	7	DEP	O
O	O	1646	1648	as	as	I-CONJP	IN	O	7	DEP	O
T4	B-Entity	1649	1654	viral	viral	B-NP	JJ	B-DNA	12	NMOD	B-DNA
T4	I-Entity	1655	1659	gene	gene	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	1660	1670	regulation	regulation	I-NP	NN	O	13	SUB	O
O	O	1671	1674	may	may	B-VP	MD	O	0	ROOT	O
O	O	1675	1681	result	result	I-VP	VB	O	13	VC	O
O	O	1682	1684	in	in	B-PP	IN	O	14	VMOD	O
O	O	1685	1688	EBV	EBV	B-NP	NN	O	19	NMOD	O
O	O	1688	1689	-	-	B-NP	HYPH	O	19	NMOD	O
O	O	1689	1699	associated	associate	I-NP	VBN	O	19	NMOD	O
O	O	1700	1707	disease	disease	I-NP	NN	O	15	PMOD	O
O	O	1707	1708	.	.	O	.	O	13	P	O
